Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Devvrat Yadav"'
Autor:
Chiranjeevi Sainatham, Devvrat Yadav, Aravind Dilli Babu, Jayanth Reddy Tallapalli, Sai Gautham Kanagala, Evgenii Filippov, Franco Murillo Chavez, Nausheen Ahmed, Forat Lutfi
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Immune cell effector therapies, including chimeric antigen receptor (CAR)-T cells, T-cell receptor (TCR) T cells, natural killer (NK) cells, and macrophage-based therapies, represent a transformative approach to cancer treatment, harnessing the immun
Externí odkaz:
https://doaj.org/article/f0abd05f4a5f47ad88dca18090e29d19
Autor:
Devvrat Yadav, Chiranjeevi Sainatham, Evgenii Filippov, Sai Gautham Kanagala, Syed Murtaza Ishaq, Thejus Jayakrishnan
Publikováno v:
Microorganisms, Vol 12, Iss 3, p 484 (2024)
Traditionally, the role of gut dysbiosis was thought to be limited to pathologies like Clostridioides difficile infection, but studies have shown its role in other intestinal and extraintestinal pathologies. Similarly, recent studies have surfaced sh
Externí odkaz:
https://doaj.org/article/5a39153def064af3bbc0e5cc1cbf9167
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Polymerase chain reaction (PCR) is a sensitive test for diagnosing Clostridioides difficile infection (CDI) and could remain positive following resolution of CDI. The kinetics of PCR positivity following antibiotics for CDI is unknown. We
Externí odkaz:
https://doaj.org/article/00bf001f2d164c5cb1966fc4ab0c7b8f
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Inflammatory bowel disease (IBD) is a chronic disease of the intestinal tract that commonly presents with diarrhea. Clostridioides difficile infection (CDI) is one of the most common complications associated with IBD that lead to flare-ups of underly
Externí odkaz:
https://doaj.org/article/6d3c4a8ada4f470db8d0515074f12d64
Autor:
Devvrat Yadav, Sahil Khanna
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Clostridioides difficile infection (CDI) is a consequence of flagrant use of antibiotics, an aging population with increasing comorbidities, and increased hospitalizations. The treatment of choice for CDI is antibiotics (vancomycin or fidaxomicin), w
Externí odkaz:
https://doaj.org/article/f735df6fb69f43779435a86019e1f2c3
Autor:
Raseen Tariq, Tausif Syed, Devvrat Yadav, Larry J. Prokop, Siddharth Singh, Edward V. Loftus, Darrell S. Pardi, Sahil Khanna
Publikováno v:
Journal of clinical gastroenterology.
Fecal microbiota transplantation (FMT) is a safe and effective therapy for recurrent Clostridioides difficile infection (CDI). Data on FMT for CDI in patients with underlying inflammatory bowel disease (IBD) are emerging but conflicting. We performed
Publikováno v:
Therapeutic Advances in Gastroenterology
Inflammatory bowel disease (IBD) is a chronic disease of the intestinal tract that commonly presents with diarrhea. Clostridioides difficile infection (CDI) is one of the most common complications associated with IBD that lead to flare-ups of underly
Publikováno v:
Gastroenterology. 162:S-558
Autor:
Devvrat, Yadav, Sahil, Khanna
Publikováno v:
Therapeutic Advances in Gastroenterology
Clostridioides difficile infection (CDI) is a consequence of flagrant use of antibiotics, an aging population with increasing comorbidities, and increased hospitalizations. The treatment of choice for CDI is antibiotics (vancomycin or fidaxomicin), w
Publikováno v:
American Journal of Gastroenterology. 116:S1393-S1393